Dudediligence.

NanoViricides, Inc

NNVCAMEX · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeSep 29 →InsidersNo open-market buys or sales.→HoldersVanguard 4.0%Geode 0.9%Connective 0.8%→Financing →PeersClosest companies: ENTA, SNGX, TOVX→

From the filings

Figures

Revenue
$0.00last 12 months
Net income
−$8.2Mlast 12 months
Operating cash flow
−$7.7Mlast 12 months
Cash and equivalents
$2.8Mat the last balance sheet
Shares outstanding
23.0M shareson issue
Every year and quarter →